{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:27:06Z","timestamp":1773948426841,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.cca.2005.11.012","type":"journal-article","created":{"date-parts":[[2005,12,28]],"date-time":"2005-12-28T14:59:58Z","timestamp":1135781998000},"page":"322-328","source":"Crossref","is-referenced-by-count":23,"title":["Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's Lymphoma Ascites tumor in mice"],"prefix":"10.1016","volume":"366","author":[{"given":"T.A.","family":"Ajith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.B.","family":"Harikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Thasna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Sabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.V.","family":"Babitha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2005.11.012_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10408399209527585","article-title":"Perspectives on toxicological risk\u2014an example: food borne carcinogenic risk","volume":"32","author":"Scheuplein","year":"1992","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.cca.2005.11.012_bib2","first-page":"99","article-title":"Oil gavage effects in tumor incidence in the national toxicology programmers two year carcinogenesis bio assay","volume":"206","author":"Appleton","year":"1985","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cca.2005.11.012_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ijc.2910150411","article-title":"Environmental factor and cancer incidence and mortality in different countries, with special reference to dietary practice","volume":"15","author":"Armstrong","year":"1975","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2005.11.012_bib4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ijc.2910580604","article-title":"Dietary fat, olive oil intake and breast cancer risk","volume":"58","author":"Martin-Moreno","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2005.11.012_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jnci\/87.2.110","article-title":"Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece","volume":"87","author":"Trichopoilon","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2005.11.012_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1383-5742(97)00035-5","article-title":"Analysis of formation of oxidative DNA damage 8\u2013hydroxy\u20132 deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis","volume":"387","author":"Kasai","year":"1997","journal-title":"Mutat Res"},{"key":"10.1016\/j.cca.2005.11.012_bib7","first-page":"48","article-title":"Diagnostic value of lipid peroxidation in lung cancer","volume":"5","author":"Vzunk","year":"2000","journal-title":"East J Med"},{"key":"10.1016\/j.cca.2005.11.012_bib8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1378\/chest.98.4.930","article-title":"Lipid peroxidation in cigarette smokers and lung cancer patients","volume":"98","author":"Petruzzelli","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.cca.2005.11.012_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/jnci\/djh123","article-title":"Apoptosis as a novel target for cancer chemoprevention","volume":"96","author":"Sun","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2005.11.012_bib10","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1074\/jbc.273.17.10618","article-title":"Inhibition of the 3-hydroxy-3 methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1\/CIP1) in human prostate carcinoma cells","volume":"273","author":"Lee","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2005.11.012_bib11","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00008469-199703001-00010","article-title":"Vitamins and cancer chemoprevention","volume":"6","author":"Giacosa","year":"1997","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.cca.2005.11.012_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/heart.85.3.259","article-title":"The statin era in search of the ideal lipid regulating agent","volume":"85","author":"Shephrd","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.cca.2005.11.012_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1445-5994.1993.tb01439.x","article-title":"Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin","volume":"23","author":"Lintott","year":"1993","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.cca.2005.11.012_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treats of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2005.11.012_bib15","first-page":"1055","article-title":"Potential antitumor effects of statins (review)","volume":"23","author":"Jakobisilak","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cca.2005.11.012_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/24.3.453","article-title":"Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models","volume":"24","author":"Shibata","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cca.2005.11.012_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxidation in animal tissues by thiobarbuturic acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2005.11.012_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-8741(02)00292-1","article-title":"Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat","volume":"84","author":"Ajith","year":"2003","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.cca.2005.11.012_bib19","first-page":"2126","article-title":"Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamine benzoylurea, a new cancericidal compound","volume":"58","author":"Jiang","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2005.11.012_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3835(95)03809-B","article-title":"Berberine complexes with DNA in the berberine induced apoptosis in human leukemic HL-60 cells","volume":"93","author":"Kuo","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cca.2005.11.012_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.278.5340.1073","article-title":"Recent advances in chemoprevention of cancer","volume":"278","author":"Hong","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cca.2005.11.012_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.1995.tb12111.x","article-title":"What are the critical attributes for cancer chemopreventive agents?","volume":"768","author":"Wattenberg","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2005.11.012_bib23","first-page":"498","article-title":"Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits","volume":"248","author":"Kornbrust","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cca.2005.11.012_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1006058409974","article-title":"Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis","volume":"50","author":"Alonso","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cca.2005.11.012_bib25","first-page":"F1","article-title":"Apoptosis regulators and their role in tumorigenesis","volume":"1551","author":"Zornig","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2005.11.012_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jnci\/92.13.1042","article-title":"Mitochondrion as a novel target of anticancer chemotherapy","volume":"92","author":"Costantini","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2005.11.012_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1535-6108(02)00241-6","article-title":"Apoptosis-targeted therapies for cancer","volume":"3","author":"Reed","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cca.2005.11.012_bib28","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/sj.leu.2402196","article-title":"Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells","volume":"15","author":"Xia","year":"2001","journal-title":"Leukemia (Baltimore)"},{"key":"10.1016\/j.cca.2005.11.012_bib29","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1158\/0008-5472.CAN-04-0866","article-title":"Blocking the Raf\/MEK\/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2005.11.012_bib30","first-page":"76","article-title":"Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP","volume":"58","author":"Marcelli","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2005.11.012_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/oxfordjournals.bmb.a072628","article-title":"Oxidative mechanism in carcinogesis","volume":"49","author":"Guyton","year":"1993","journal-title":"Br Med Bull"},{"key":"10.1016\/j.cca.2005.11.012_bib32","first-page":"276","article-title":"Comparison of the mutagenecity of MDA and the side products formed during its chemical synthesis","volume":"40","author":"Marnett","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2005.11.012_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1076\/apab.109.4.331.4248","article-title":"Evaluation of oxidative stress in patients with cancer","volume":"109","author":"Hristozov","year":"2001","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.cca.2005.11.012_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006357330486","article-title":"Lipid peroxidation, free radical production and antioxidant status in breast cancer","volume":"59","author":"Ray","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cca.2005.11.012_bib35","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1016\/S0361-090X(02)00093-4","article-title":"Potential role of lipid peroxidation-derived DNA damage in human colon carcinogenesis: studies on exocyclic base adducts as stable oxidative stress marker","volume":"26","author":"Bartsch","year":"2002","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.cca.2005.11.012_bib36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/carcin\/11.9.1447","article-title":"The role of 8-hydroxyguanine in carcinogenesis","volume":"11","author":"Floyd","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cca.2005.11.012_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-5273(02)00577-6","article-title":"A comparative study of the in vitro antioxidant activity of statins","volume":"90","author":"Franzoni","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2005.11.012_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/15376520590918766","article-title":"Statins and modulation of oxidative stress","volume":"15","author":"Beltowski","year":"2005","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.cca.2005.11.012_bib39","series-title":"Methods in plant biochemistry","first-page":"71","article-title":"Assays related to cancer drug discovery","author":"Suffness","year":"1991"},{"key":"10.1016\/j.cca.2005.11.012_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1471-4159.1996.66020710.x","article-title":"Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells","volume":"66","author":"Prasanna","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.cca.2005.11.012_bib41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/carcin\/22.8.1139","article-title":"Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study","volume":"22","author":"Denoyelle","year":"2001","journal-title":"Carcinogenesis (Lond)"},{"key":"10.1016\/j.cca.2005.11.012_bib42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/carcin\/22.7.1061","article-title":"HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2","volume":"22","author":"Wachtershauser","year":"2001","journal-title":"Carcinogenesis (Lond)"},{"key":"10.1016\/j.cca.2005.11.012_bib43","first-page":"2761","article-title":"Inhibition of Ras farnesylation by lovastatin leads to down-regulation of proliferation and migrating in primary cultured human gliblastoma cells","volume":"20","author":"Bouterfa","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2005.11.012_bib44","first-page":"483","article-title":"Phase I study of lovastatin, an inhibitor of the mevalonate pathway in patients with cancer","volume":"2","author":"Thibault","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cca.2005.11.012_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000421-199812000-00010","article-title":"A Phase I\u2013II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme","volume":"21","author":"Larner","year":"1998","journal-title":"Am J Clin Oncol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105006844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105006844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T15:29:34Z","timestamp":1555082974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898105006844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0009898105006844"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2005.11.012","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}